Question 1

What is congenital afibrinogenemia?

Accepted Answer

Congenital afibrinogenemia is a bleeding disorder that results from a complete absence of circulating fibrinogen, a critical blood clotting protein. This condition is caused by pathogenic variants in the genes FGA, FGB, and FGG, and it is inherited in an autosomal recessive manner. It is typically identified in infancy due to abnormal bleeding episodes, although precise prevalence estimates are not well established.

Question 2

What are the symptoms of congenital afibrinogenemia?

Accepted Answer

The clinical picture of congenital afibrinogenemia is defined by the consistent absence of fibrinogen, resulting in abnormal bleeding that is present in all affected individuals. Characteristic features include persistent abnormal bleeding, with many patients experiencing issues such as abnormal umbilical stump bleeding, epistaxis, and prolonged bleeding following procedures like circumcision. Other less common manifestations can include subdural or epidural hemorrhage, prolonged bleeding after dental extractions, and bruising susceptibility. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes congenital afibrinogenemia?

Accepted Answer

Congenital afibrinogenemia arises from variants in the FGA, FGB, and FGG genes, which encode the protein fibrinogen that is essential for blood clotting. The complete absence of fibrinogen due to these genetic defects leads to a marked bleeding tendency. In this autosomal recessive disorder, an individual must inherit two mutated copies, one from each parent, to be affected. Genetic counseling is recommended for families to better understand the inheritance pattern and implications for future pregnancies. Associated genes include FGA, FGB, FGG.

Question 4

How is congenital afibrinogenemia inherited?

Accepted Answer

congenital afibrinogenemia follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is congenital afibrinogenemia diagnosed?

Accepted Answer

Diagnosis of congenital afibrinogenemia is primarily confirmed through molecular genetic testing, which identifies pathogenic variants in the FGA, FGB, and FGG genes. Clinical evaluation is also essential, with a focus on the history of abnormal bleeding and related laboratory findings. As symptoms of this condition can overlap with other bleeding disorders, comprehensive testing is necessary to distinguish it from similar conditions.

Question 6

Are there treatments for congenital afibrinogenemia?

Accepted Answer

Currently, management of congenital afibrinogenemia focuses on supportive care and symptom management, as there are no FDA-approved treatments specifically for this condition. Therapeutic strategies are personalized and may involve the use of fibrinogen replacement during bleeding episodes, along with measures to prevent bleeding complications. Management typically involves a multidisciplinary team, and patients should discuss treatment options with their healthcare team. Genetic counseling is also recommended as part of overall care.

Question 7

Are there clinical trials for congenital afibrinogenemia?

Accepted Answer

Yes, there are currently 5 active clinical trials for congenital afibrinogenemia registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from congenital afibrinogenemia?

Accepted Answer

Complications from congenital afibrinogenemia can include severe bleeding episodes, which may occur spontaneously or after injuries. Some patients may experience prolonged bleeding after dental procedures or surgeries, and there is a risk of internal bleeding, such as subdural or epidural hemorrhages. The severity of these complications can vary significantly from person to person.

Question 9

How does congenital afibrinogenemia affect daily life?

Accepted Answer

Living with congenital afibrinogenemia means being cautious about activities that could lead to bleeding. Patients often need to avoid high-risk sports and take extra care during medical procedures. Regular check-ups with healthcare providers and a personalized management plan are important to help prevent and address bleeding episodes effectively.

Question 10

What is the life expectancy for someone with congenital afibrinogenemia?

Accepted Answer

The life expectancy for individuals with congenital afibrinogenemia can vary widely. Many people manage their condition well into adulthood, especially with prompt and effective care for bleeding episodes. However, the unpredictability of bleeding complications can affect overall health, so regular medical support is essential for maintaining a good quality of life.

Question 11

What specialists should be involved in the care of someone with congenital afibrinogenemia?

Accepted Answer

Patients with congenital afibrinogenemia should work with a multidisciplinary team that includes hematologists, who specialize in blood disorders. Genetic counselors can also provide valuable information about the condition and its inheritance. Collaborating with these specialists helps ensure comprehensive care and support for managing the disease effectively.

Research Type	Count	% of Total
Patient case studies	34	27%
Research summaries	26	21%
Disease patterns and progression	23	18%
Laboratory research	13	10%
Testing and diagnosis research	11	9%
Clinical study results	10	8%
Other research	5	4%
New treatment approaches	3	2%

Kisho

congenital afibrinogenemia

Overview

Clinical Presentation

Genetic Landscape

FGA

FGB

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

FGG

Recent Publications

Latest News & Developments

Perianal Crohn Disease in a Patient With Congenital Afibrinogenemia: A Multidisciplinary Therapeutic Management Challenge.

congenital afibrinogenemia

Overview

Clinical Presentation

Genetic Landscape

FGA

FGB

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Orphanet

GARD

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital afibrinogenemia?

What are the symptoms of congenital afibrinogenemia?

What causes congenital afibrinogenemia?

How is congenital afibrinogenemia inherited?

How is congenital afibrinogenemia diagnosed?

Are there treatments for congenital afibrinogenemia?

Are there clinical trials for congenital afibrinogenemia?

What complications can arise from congenital afibrinogenemia?

How does congenital afibrinogenemia affect daily life?

What is the life expectancy for someone with congenital afibrinogenemia?

What specialists should be involved in the care of someone with congenital afibrinogenemia?

Explore clinical features

FGG

Recent Publications

Latest News & Developments

Perianal Crohn Disease in a Patient With Congenital Afibrinogenemia: A Multidisciplinary Therapeutic Management Challenge.